EHC Stock Chart & Stats
$1920.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1920.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,679.80 - $2,622.39
Previous CloseN/A
Volume0.00
Average Volume (3M)5.00
Market Cap
$244.94B
Enterprise Value$15.70B
Total Cash (Recent Filing)$76.20M
Total Debt (Recent Filing)$2.80B
Price to Earnings (P/E)20.3
Beta-0.26
Next Earnings
Feb 11, 2027EPS Estimate
30.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.48
Shares Outstanding98,653,380
10 Day Avg. Volume0
30 Day Avg. Volume5
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)4.37
Price to Sales (P/S)1.80
P/FCF Ratio24.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2,842.82Price Target Upside48.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)114.06
Revenue Forecast (FY)$120.56B
Bulls Say, Bears Say
Bulls Say
Profitable GrowthConsistent growth in revenue, EBITDA, and earnings indicates that Encompass Health is converting rising rehabilitation demand into improving profitability. The combination of discharge growth, higher acuity, and stronger margins supports durable earnings expansion and provides resources for continued investment in hospitals and clinical services.
Expansion PipelineA substantial development pipeline gives Encompass Health multiple avenues to expand capacity and capture demand over the next several years. New hospitals, bed additions, and a stated goal of six to ten openings annually can support sustained volume growth while broadening the company’s national rehabilitation network.
Clinical PositionBroad clinical certification and leadership in stroke rehabilitation strengthen Encompass Health’s reputation with patients, physicians, and referral sources. These capabilities support high-acuity care, reinforce the company’s position in a specialized service category, and may help sustain demand as rehabilitation needs increase.
Bears Say
Medicaid Funding PressureThe sharp reduction in Medicaid supplemental and provider-tax contributions creates a lower reimbursement tailwind than the company recently received. Even if core operating performance remains strong, reduced supplemental funding can pressure EBITDA growth and make earnings more dependent on admissions, pricing, acuity, and cost control.
RCD Processing RiskThe expanded RCD program introduces an administrative execution risk across a much larger hospital population, with 100% prepayment claim review scheduled for the first half of the year. Processing delays could slow reimbursement and temporarily increase working-capital needs even if claims ultimately qualify for payment.
Capacity ConstraintsHigh occupancy at a sizeable group of hospitals indicates that demand is outpacing available beds in important markets. Until planned additions are completed, these constraints can limit admissions and revenue growth, reduce the company’s ability to serve referrals, and shift execution emphasis toward timely expansion.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $1679.80 and its highest was $2622.39 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $244.94B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Feb 11, 2027 which is in 103 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Oct 28, 2026. The company reported $28.701 earnings per share for the quarter, beating the consensus estimate of $25.699 by $3.002.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health does not currently pay dividends.
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 30.44.
How many shares outstanding does Encompass Health have?
Encompass Health has 98,653,380 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $28.701 in its last earnings report, beating expectations of $25.699. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in MX:EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2,842.82 (48.06% Upside)
$2,842.82 (48.06% Upside)
Blogger Sentiment
Bullish
MX:EHC Sentiment 78%
Sector Average 64%
Sector Average 64%
Insider Transactions
Sold Shares
Worth $490.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.43%
12-Months-Change
Fundamentals
Return on Equity
25.17%
Trailing 12-Months
Asset Growth
10.21%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Encompass Health
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
EHC Company Deck
EHC Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive overall. The company reported broad-based revenue, EBITDA, EPS, cash flow, volume, acuity, staffing, and capacity growth, raised 2026 guidance again, and highlighted favorable demand, clinical outcomes, development opportunities, and capital flexibility. The main challenges were higher bad debt from a one-time system conversion, lower Medicaid supplemental payment contributions, pending Florida CMS approval, elevated pre-opening costs, Medicare Advantage discharge pressure, capacity constraints, and administrative uncertainty around RCD expansion. Management characterized several of these issues as one-time, temporary, or manageable, while the number and strength of the highlighted achievements significantly outweighed the stated challenges.View all MX:EHC earnings summariesEHC Stock 12 Month Forecast
Average Price Target
$2,842.82
▲(48.06% Upside)
Technical Analysis
National Healthcare
―
The Ensign Group
―
Pennant Group
―
Aveanna Healthcare Holdings
―
PACS Group Inc
―